A Case of Serotonin Syndrome Caused by the Concomitant Utilization of Methylene Blue and Venlafaxine in an Oncological Patient. (October 2020)

• Record Type: Journal Article
• Authors: Gilbert, Brian; Akamune, Inyang E.
• Is Part Of: Journal of pharmacy practice. Volume 33:Number 5(2020:Oct.)
• Page Start: 705
• Page End: 707
• Publication Date: 2020-10
• Subjects: serotonin syndrome -- methylene blue -- venlafaxine -- drug interaction -- adverse drug event; Pharmacy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1177/0897190019850706
• Languages: English
• ISSNs: 0897-1900

Abstract

Although the interaction between methylene blue and serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors is well documented, there remains a paucity of literature on identifying patient groups who may be at risk for experiencing this interaction. Here, we report a case of methylene blue and venlafaxine-induced serotonin syndrome in a patient with cancer.